|Committee Member||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness||Voting Recusals by Section∗|
|Rick A. Nishimura (Co-Chair)||Mayo Clinic, Division of Cardiovascular Disease—Judd and Mary Morris Leighton Professor of Medicine||None||None||None||None||None||None||None|
|Catherine M. Otto (Co-Chair)||University of Washington Division of Cardiology—Professor of Medicine||None||None||None||None||None||None||None|
|Robert O. Bonow||Northwestern University Feinberg School of Medicine—Goldberg Distinguished Professor of Cardiology||None||None||None||None||None||None||None|
|Blase A. Carabello||East Carolina University, Brody School of Medicine, East Carolina Heart Institute—Chief Cardiology Director||None||None||None||None||3.2.4, 7.3.3, 7.4.3, and 11.1.|
|John P. Erwin III||Texas A&M College of Medicine, Baylor Scott and White Health—Senior Staff Cardiologist, Clinical Professor and Chair of Internal Medicine||None||None||None||None||None||None||None|
|Lee A. Fleisher||University of Pennsylvania, Department of Anesthesiology—Professor of Anesthesiology||None||None||None||None||None||None||None|
|Hani Jneid||Baylor College of Medicine—Associate Professor of Medicine, Director of Interventional Cardiology Research; The Michael E. DeBakey VA Medical Center—Director of Interventional Cardiology||None||None||None||None||None||None||None|
|Michael J. Mack||The Heart Hospital Baylor Plano—Director||None||None||None||None||None||3.2.4, 7.3.3, 7.4.3, and 11.1.|
|Christopher J. McLeod||Mayo Clinic, Division of Cardiovascular Disease—Assistant Professor of Medicine||None||None||None||None||None||None||None|
|Patrick T. O’Gara||Brigham and Women’s Hospital—Professor of Medicine; Harvard Medical School—Director of Clinical Cardiology||None||None||None||None||None||None||None|
|Vera H. Rigolin||Northwestern University Feinberg School of Medicine—Professor of Medicine; Northwestern Memorial Hospital—Medical Director, Echocardiography Laboratory||None||None||None||None||None||None|
|Thoralf M. Sundt III||Massachusetts General Hospital—Chief, Division of Cardiac Surgery, Harvard Medical School—Professor of Surgery||None||None||None||None||3.2.4, 7.3.3, 7.4.3, and 11.1.|
|Annemarie Thompson||Duke University Medical Center—Department of Anesthesiology, Professor of Anesthesiology; Residency Program Director||None||None||None||None||None||None||None|
This table represents relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or c) the person or a member of the person's household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
ACC indicates American College of Cardiology; AHA, American Heart Association; Partner, Placement of Aortic Transcatheter Valve; Perigon, Pericardial Surgical Aortic Valve Replacement; and VA, Veterans Affairs.